21st Century Cures Initiative
- White Paper Response: 21st Century Cures
- UMR responds to Chairman Fred Upton’s (R-MI) and Representative Diana DeGette’s (D-CO) 21st Century Cures initial white paper entitled, “21st Century Cures: A Call to Action”.
- UMR supports continuing our nation’s commitment to biomedical research, so that the United States remains the world leader in the life sciences.
- UMR requests that the 21st Century Cures Initiative include a strategy for providing NIH with a path to stable, sustainable and predictable funding growth.
- For more info on the 21st Century Cures initiative, click here.
Letters to Congress & Congressional Testimony
- Letters in Support of Legislation
- Letter to Congressional Leaders on 21st Century Cures (November 2016)
- Letter to House Leaders on 21st Century Cures (October 2016)
- Letter to Senate Leaders on 21st Century Cures (October 2016)
- Letter in Support of Senate Innovations Package (April 2016)
- Letter in support of Senator Richard Durbin’s (D-IL) American Cures Act (S. 2658), which seeks to ensure stable funding for NIH (March 2014)
- Letter in support of Representative Anna Eshoo’s (D-CA) American HEALS Act (HR 4384), which seeks to ensure stable funding for NIH (April 2014)
- Letter in support of Senator Tom Harkin’s (D-IA) Accelerating Biomedical Research Act (S. 2658), which seeks to increase funding for NIH (July 2014)
- Information on Appropriations
- Letter to House and Senate Appropriations Chairs and Ranking Members on FY17 and FY18 funding for NIH (4.11.17)
- Letter to House and Senate Appropriations Chairs and Ranking Members supporting at least $34.5 billion for NIH in FY17
- Letter to House and Senate Appropriations Chairs and Ranking Members supporting the inclusion of the Senate provisions related to NIH in the final FY15 spending bill (November 2014)
- Letter to House Appropriators requesting $32 billion in funding for NIH, $2.1 billion above FY14 (June 2014)
- Letter to Senate Appropriators requesting $32 billion in funding for NIH, $2.1 billion above FY14 (June 2014)
- Testimony to House Appropriations Committee in support of $32 billion for NIH in FY15 (March 2014)
- Letter to House and Senate Appropriations Chairs and Ranking Members on the FY15 302(b) allocation for the Labor, Health and Human Services, and Education spending bill (February 2014)
NIH’s Impact on the U.S. Economy
State-by-State Impact of NIH Funding
- Profiles of Prosperity: How NIH-Supported Research is Fueling Private Sector Growth and Innovation (July 2013)
In the wake of drastic sequestration cuts that have flatlined funding for medical research, this report highlights a diverse range of innovative life science companies large and small who trace their core advances to National Institutes of Health (NIH) funding.
- The Impact of Genomics on the U.S. Economy (June 2013)
This report is an update to the highly cited Battelle 2011 report tracking the growth of the genomics industry and its links to the federally-funded Human Genome Project (HGP). This 2013 update demonstrates that the Human Genome Project and related research continue to yield significant U.S. economic growth.